Cutler Group LP Vertex Pharmaceuticals Inc Put Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Put Options

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 25, 2022	SELL	$273.83 - $305.53 $5.94 Million - $6.63 Million	-21,700 Reduced 93.53%	1,500 $0
Q2 2022 Aug 04, 2022	SELL	$234.96 - $292.55 $399,432 - $497,335	-1,700 Reduced 6.83%	23,200 $60,000
Q1 2022 Apr 14, 2022	BUY	$221.42 - $260.97 $4.87 Million - $5.74 Million	22,000 Added 758.62%	24,900 $143,000
Q4 2021 Jan 18, 2022	BUY	$177.01 - $223.45 $477,927 - $603,315	2,700 Added 1350.0%	2,900 $14,000
Q2 2021 Jul 19, 2021	SELL	$187.49 - $221.1 $281,235 - $331,650	-1,500 Reduced 88.24%	200 $1,000
Q1 2021 Apr 26, 2021	BUY	$207.02 - $241.31 $310,530 - $361,965	1,500 Added 750.0%	1,700 $36,000
Q4 2020 Jan 21, 2021	SELL	$207.01 - $276.09 $993,648 - $1.33 Million	-4,800 Reduced 96.0%	200 $2,000
Q1 2020 May 07, 2020	BUY	$199.77 - $247.81 $39,954 - $49,562	200 Added 4.17%	5,000 $11,000
Q1 2019 May 10, 2019	SELL	$163.73 - $194.7 $2.42 Million - $2.88 Million	-14,800 Reduced 75.51%	4,800 $67,000
Q4 2018 Feb 05, 2019	BUY	$151.91 - $192.21 $653,213 - $826,503	4,300 Added 28.1%	19,600 $176,000
Q3 2018 Nov 07, 2018	SELL	$167.73 - $192.74 $419,325 - $481,850	-2,500 Reduced 14.04%	15,300 $75,000
Q2 2018 Aug 10, 2018	BUY	$145.72 - $169.96 $597,452 - $696,836	4,100 Added 29.93%	17,800 $124,000
Q1 2018 May 11, 2018	SELL	$151.6 - $177.13 $5.44 Million - $6.36 Million	-35,900 Reduced 72.38%	13,700 $164,000
Q4 2017 Jan 17, 2018	SELL	$137.28 - $155.55 $4.09 Million - $4.64 Million	-29,800 Reduced 37.53%	49,600 $207,000
Q3 2017 Oct 17, 2017	BUY	$148.13 - $162.24 $11.8 Million - $12.9 Million	79,400	79,400 $212,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account